Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $10.4866 per ML under NDC 62332059805. Its NADAC has been published 144 times since Jan 3, 2024.
FDA first approved this application on Apr 5, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
15 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332059805
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Generic (ANDA)
FDA Application
ANDA214588FDA Approved
4/5/2023
TE Code
AT
On Market Since
4/5/2023
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 144 times since Jan 3, 2024, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.4866 per ML |
|---|---|
| All-time high | $23.3947 (Dec 11, 2024) |
| All-time low | $10.4866 (Sep 23, 2026) |
| 52-week high | $14.6492 |
| 52-week low | $10.4866 |
| Median price | $15.1043 |
| Average price | $15.8468 |
| Largest weekly change | +49.6% (Nov 20, 2024) |
| Weeks tracked | 144 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bepotastine Besilate Ophthalmic Solution 1.5% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $10.4866 per ML (NDC 62332059805), effective Sep 30, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 48.9%. It has been tracked across 144 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Jan 3, 2024, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $10.4866 (Sep 23, 2026) to a high of $23.3947 (Dec 11, 2024), with a median of $15.1043 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BEPOTASTINE 1.5% EYE DROP, is $8.2857 per ML — about 21% below BEPOTASTINE 1.5% EYE DROP.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 62332059805) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.